KATRINA POTITHAVORANANT: Open Payments
NPI 1710348479 · SAINT PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 40 payments from 14 companies in 2025. Trend: 2023 $209 · 2024 $870 · 2025 $861
Food & beverage: $861
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $192 |
| Novo Nordisk Inc | 5 | $96 |
| GlaxoSmithKline, LLC. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| Lilly USA, LLC | 5 | $80 |
| PFIZER INC. | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 1 | $58 |
| Dynavax Technologies Corporation | 2 | $43 |
| Abbott Laboratories | 2 | $41 |
| Amgen Inc. | 2 | $29 |
Products named: UBRELVY, TRELEGY ELLIPTA, LEQVIO, MOUNJARO, Wegovy, VRAYLAR, NURTEC ODT, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
